Articles

Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression

Cancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, China;Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Immunology Department of Medical College, Nanchang University, Jiangxi, China
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Cancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, China
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Cancer Research Institute and Cancer Hospital, Guangzhou Medical University, China
Vol. 102 No. 7 (2017): July, 2017 https://doi.org/10.3324/haematol.2016.154062